MR-Linac Consortium
@mrlconsortium.bsky.social
Behind the MR‑Linac Consortium's progress is a group dedicated to advancing what’s possible in cancer care.
The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.
The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.
February 16, 2026 at 2:18 PM
Behind the MR‑Linac Consortium's progress is a group dedicated to advancing what’s possible in cancer care.
The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.
The Clinical Steering Committee drives research focus, quality excellence, and global collaboration—fueling the rapid expansion of MR‑guided radiotherapy and improving outcomes for patients.
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.
February 10, 2026 at 9:22 AM
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.
February 2, 2026 at 3:52 PM
Registrations are now open for our upcoming Consortium Knowledge Exchange webinar! We welcome Clement Chevillard and Vincent Domec from Hôpital René Huguenin – Institut Curie, France, who will present on their experience integrating the Elekta Unity into a mixed vendor environment.
Abstract submissions for the MR‑Linac Consortium Meeting 2026 are now open! We welcome your research and insights as we prepare for an exciting gathering in Montreal.
Submit your abstract today via the link in your emails or on the member portal.
lnkd.in/ef3TrgGS
#ProgressThroughCollaboration
Submit your abstract today via the link in your emails or on the member portal.
lnkd.in/ef3TrgGS
#ProgressThroughCollaboration
January 27, 2026 at 11:48 AM
Abstract submissions for the MR‑Linac Consortium Meeting 2026 are now open! We welcome your research and insights as we prepare for an exciting gathering in Montreal.
Submit your abstract today via the link in your emails or on the member portal.
lnkd.in/ef3TrgGS
#ProgressThroughCollaboration
Submit your abstract today via the link in your emails or on the member portal.
lnkd.in/ef3TrgGS
#ProgressThroughCollaboration
Ready to spotlight your expertise in MR-guided Radiotherapy (MRgRT)?
We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡
Submit your entry today! lnkd.in/e3cc6-2k
We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡
Submit your entry today! lnkd.in/e3cc6-2k
January 5, 2026 at 9:27 AM
Ready to spotlight your expertise in MR-guided Radiotherapy (MRgRT)?
We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡
Submit your entry today! lnkd.in/e3cc6-2k
We’re looking for standout content: creative media, inspiring clinical cases, and innovative approaches that highlight the real impact of MRgRT in transforming treatment. 💡
Submit your entry today! lnkd.in/e3cc6-2k
Radiographer-led adaptive #MRgRT workflows are reshaping radiotherapy, streamlining processes, and improving patient experience.
Hear Charlie Tran from GenesisCare Australia :
lnkd.in/erTKBt6C
#ProgressThroughCollaboration
mrlconsortium.org
Hear Charlie Tran from GenesisCare Australia :
lnkd.in/erTKBt6C
#ProgressThroughCollaboration
mrlconsortium.org
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
December 15, 2025 at 12:11 PM
Radiographer-led adaptive #MRgRT workflows are reshaping radiotherapy, streamlining processes, and improving patient experience.
Hear Charlie Tran from GenesisCare Australia :
lnkd.in/erTKBt6C
#ProgressThroughCollaboration
mrlconsortium.org
Hear Charlie Tran from GenesisCare Australia :
lnkd.in/erTKBt6C
#ProgressThroughCollaboration
mrlconsortium.org
Celebrating Global Collaboration in MR-Linac Research!
The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy.
Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq
The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy.
Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
November 17, 2025 at 10:48 AM
Celebrating Global Collaboration in MR-Linac Research!
The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy.
Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq
The MR-Linac Consortium continues to thrive as a truly international community, united by a shared mission to advance precision radiation therapy.
Don’t miss this conversation with Dr. Qian Peng, Radiation Oncologist in China: lnkd.in/eve3usMq
At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!
November 12, 2025 at 10:46 AM
At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!
We are thrilled that Rad Chat joined us at the MR-Linac Consortium meeting!
Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes
Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes
November 7, 2025 at 4:10 PM
We are thrilled that Rad Chat joined us at the MR-Linac Consortium meeting!
Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes
Rad Chat is a multi award winning podcast, education and social media platform focusing on radiotherapy and oncology. Curious to hear what Consortium attendees shared with them. Listen here: radchat.transistor.fm/episodes
Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.
November 7, 2025 at 11:24 AM
Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.
The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.
November 5, 2025 at 11:18 AM
The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.
📄 This MOMENTUM study highlights the safety and tolerability of MRI-guided SBRT for liver metastases, showing promising results in maintaining disease control with manageable side effects. Patients reported a stable quality of life throughout treatment.
lnkd.in/eN8sEzmz
#MOMENTUM #LiverCancer
lnkd.in/eN8sEzmz
#MOMENTUM #LiverCancer
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
October 24, 2025 at 8:58 AM
📄 This MOMENTUM study highlights the safety and tolerability of MRI-guided SBRT for liver metastases, showing promising results in maintaining disease control with manageable side effects. Patients reported a stable quality of life throughout treatment.
lnkd.in/eN8sEzmz
#MOMENTUM #LiverCancer
lnkd.in/eN8sEzmz
#MOMENTUM #LiverCancer
Research from UTSW explores how PSMA-PET imaging can guide adaptive SABR in high-risk prostate cancer—refining tumor boosts based on response, without adding treatment time. MR-Linac and CBCT systems can offer practical paths to personalized, biology-driven radiotherapy.
lnkd.in/e4pHnZg2
lnkd.in/e4pHnZg2
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
October 8, 2025 at 1:23 PM
Research from UTSW explores how PSMA-PET imaging can guide adaptive SABR in high-risk prostate cancer—refining tumor boosts based on response, without adding treatment time. MR-Linac and CBCT systems can offer practical paths to personalized, biology-driven radiotherapy.
lnkd.in/e4pHnZg2
lnkd.in/e4pHnZg2
We’re thrilled to announce that the speaker lineup for the MR-Linac Consortium Meeting this November is confirmed!
Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.
Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.
October 3, 2025 at 9:29 AM
We’re thrilled to announce that the speaker lineup for the MR-Linac Consortium Meeting this November is confirmed!
Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.
Last year’s meeting brought together brilliant minds, bold ideas, and transformative conversations in MR-guided radiotherapy and this year promises to be even more impactful.
This study explores the feasibility and early outcomes of MR-guided stereotactic ablative radiotherapy (MRgSTAR) for patients with synchronous oligometastatic prostate cancer (OMPC).
✅ 100% 3-year overall survival
✅ 95.2% progression-free survival
www.frontiersin.org/journals/onc...
✅ 100% 3-year overall survival
✅ 95.2% progression-free survival
www.frontiersin.org/journals/onc...
Frontiers | Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer
ObjectivesTo prospectively investigate the feasibility, toxicity, and preliminary clinical outcomes of magnetic resonance (MR)-guided stereotactic total abla...
www.frontiersin.org
September 22, 2025 at 12:53 PM
This study explores the feasibility and early outcomes of MR-guided stereotactic ablative radiotherapy (MRgSTAR) for patients with synchronous oligometastatic prostate cancer (OMPC).
✅ 100% 3-year overall survival
✅ 95.2% progression-free survival
www.frontiersin.org/journals/onc...
✅ 100% 3-year overall survival
✅ 95.2% progression-free survival
www.frontiersin.org/journals/onc...
This retrospective analysis of five patients treated in the MOMENTUM study highlights that daily MR-adaptation reduces dose variability and OAR exposure compared to MR-guided plans alone for cervical cancer.
#CervicalCancer #MOMENTUM
medicaljournalssweden.se/actaoncologi...
#CervicalCancer #MOMENTUM
medicaljournalssweden.se/actaoncologi...
Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancer
| Acta Oncologica
medicaljournalssweden.se
September 11, 2025 at 2:00 PM
This retrospective analysis of five patients treated in the MOMENTUM study highlights that daily MR-adaptation reduces dose variability and OAR exposure compared to MR-guided plans alone for cervical cancer.
#CervicalCancer #MOMENTUM
medicaljournalssweden.se/actaoncologi...
#CervicalCancer #MOMENTUM
medicaljournalssweden.se/actaoncologi...
August 19, 2025 at 1:49 PM
🚨A recent study leveraging MOMENTUM’s extensive dataset underlines that online adaptive MR-guided radiotherapy (MRgRT) shows promise for patients with non-metastatic pancreatic cancer.
✅ Maintained quality of life
✅ Significant symptom improvement at 6 months
www.redjournal.org/article/S036...
✅ Maintained quality of life
✅ Significant symptom improvement at 6 months
www.redjournal.org/article/S036...
Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy
Online adaptive magnetic resonance guided radiation therapy (MRgRT) using a hybrid
magnetic resonance imaging and linear accelerator enables stereotactic ablative radiation
doses to pancreatic tumors....
www.redjournal.org
August 14, 2025 at 1:56 PM
🚨A recent study leveraging MOMENTUM’s extensive dataset underlines that online adaptive MR-guided radiotherapy (MRgRT) shows promise for patients with non-metastatic pancreatic cancer.
✅ Maintained quality of life
✅ Significant symptom improvement at 6 months
www.redjournal.org/article/S036...
✅ Maintained quality of life
✅ Significant symptom improvement at 6 months
www.redjournal.org/article/S036...
Advancing MR-Guided Radiotherapy in Esophageal Cancer
A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.
A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.
A simplified online adaptive workflow for long-course magnetic resonance-guided radiotherapy in esophageal cancer
Since the publication of the landmark CROSS trial in 2012 [1], neoadjuvant chemoradiotherapy
has become a cornerstone in the curative treatment of esophageal cancer in much of
the western world. The r...
www.phiro.science
August 6, 2025 at 3:54 PM
Advancing MR-Guided Radiotherapy in Esophageal Cancer
A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.
A recent study from UMC Utrecht, explores the ATS-lite workflow—a simplified approach to online adaptive MRgRT which streamlines treatment delivery to a median of 23 minutes, while maintaining 90% target coverage.
Researchers in Nijmegen, Netherlands, have created an open-access online tool for early economic evaluation. This tool provides insights into the cost-effectiveness of MRIgRT. lnkd.in/e2sRxFRs
Users can input their own data lnkd.in/erDkxXpF
www.mrlconsortium.org
hashtag#ProgressThroughCollaboration
Users can input their own data lnkd.in/erDkxXpF
www.mrlconsortium.org
hashtag#ProgressThroughCollaboration
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
August 1, 2025 at 2:20 PM
Researchers in Nijmegen, Netherlands, have created an open-access online tool for early economic evaluation. This tool provides insights into the cost-effectiveness of MRIgRT. lnkd.in/e2sRxFRs
Users can input their own data lnkd.in/erDkxXpF
www.mrlconsortium.org
hashtag#ProgressThroughCollaboration
Users can input their own data lnkd.in/erDkxXpF
www.mrlconsortium.org
hashtag#ProgressThroughCollaboration
Reposted by MR-Linac Consortium
Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social
June 27, 2025 at 11:12 AM
Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social